Commercial teams invest heavily in doctor and KOL engagement, then struggle to prove it worked. The problem is almost never the analysis. It is that engagement and prescription data were never connected in the first place.
Attribution is a design decision
If field activity and Rx data live in separate systems with no common key, no after-the-fact analysis can bridge them. Attribution has to be built into the programme design, defined touchpoints, tracking and a shared identifier.
Structure beats volume
Structured engagement journeys outperform high-volume unstructured activity, and they generate the data trail that makes ROI measurable in the first place.
Compliance and measurability go together
The same structure that makes engagement auditable under UCPMP makes it measurable. Governance and ROI are not a trade-off.
How Ichelon helps
We link CRM activity to Rx attribution from the start and feed it into BI, and Pharos RxFlow and Pulse make the prescription picture visible at HCP and territory level.
Ready to apply this thinking?
Start a pilot project and evaluate Ichelon's quality within one delivery cycle.